Clin2
NCT07132788Possibly a fitRecruiting

Study of pulmonary arterial hypertension and lean muscle mass

Pulmonary Hypertension

Treatments studied

Part of Heart & circulation, Lungs & breathing clinical trials.

This study looks at how pulmonary arterial hypertension (PAH) affects lean muscle mass. It aims to understand the relationship between PAH and muscle loss, which could help improve treatments and quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have a confirmed diagnosis of pulmonary arterial hypertension (PAH).
  • Your PAH is one of these types: idiopathic, heritable, drug/toxin-induced, or associated with connective tissue disease, HIV, congenital heart disease, or portopulmonary hypertension.
  • Your PAH was diagnosed within the last 6 months, or you are on stable treatment for at least 3 months.
  • You do not have severe lung disease (COPD or restrictive lung disease).
  • You have not been hospitalized for heart failure in the last week.
  • You do not have moderate or severe aortic or mitral valve disease.
  • Your heart's ejection fraction is not below 40% (within the last year).
  • You are not pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT01730092Recruiting
Study of blood and imaging biomarkers in pulmonary artery hypertension

This study tracks natural changes in “biomarkers” (measurable signals in blood) and imaging findings in people with pulmonary arterial hypertension (PAH) or suspected PAH. It also includes healthy people for comparison, helping researchers understand what these signals mean over time.

Bethesda, Maryland
NCT07151768Recruiting
Validating a risk score for lung disease patients with pulmonary hypertension

This study is testing whether a new risk score can better predict outcomes for people who have both chronic lung disease and pulmonary hypertension (high blood pressure in the lungs). If you qualify, the researchers will follow your health over time to see how well the score works.

Philadelphia, Pennsylvania
NCT07149935Recruiting
Exercise training for pulmonary arterial hypertension

This study tests whether a special exercise training program can help people with pulmonary arterial hypertension (PAH) feel better and stay stable. If you have mild-to-moderate PAH and are on stable medication, you may be able to join.

Shanghai, Shanghai Municipality
NCT05958901Recruiting
Study of pulmonary hypertension in everyday clinical care

This observational study is looking at people diagnosed with pulmonary hypertension to better understand how it behaves over time. You may help researchers by allowing repeated check-ins for years and sharing symptom and test information.

Guangzhou, Guangdong
NCT07184671Not yet recruiting
Studying lung tissue to understand pulmonary hypertension

This study looks at lung tissue from surgery to learn how pulmonary hypertension (high blood pressure in the lungs) develops in people with lung disease. The goal is to find better ways to diagnose and treat this condition.

NCT06931886Enrolling by invitation
Breathing training for pulmonary hypertension

This trial tests if special breathing exercises can help people with pulmonary hypertension. You may join if your condition is stable and you haven't smoked in the last 10 years.

Tucson, Arizona

Hear when a new Pulmonary Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.